扫描二维码，直接登录
题库 / Prep2007E1-CR-44
In countries in which new life-sustaining drugs cannot be patented, such drugs are sold at widely affordable prices; those same drugs, where patented, command premium prices because the patents shield patent-holding manufacturers from competitors. These facts show that future access to new life-sustaining drugs can be improved if the practice of granting patents on newly developed life-sustaining drugs were to be abolished everywhere.
Which of the following, if true, most seriously weakens the argument?
In countries in which life-sustaining drugs cannot be patented, their manufacture is nevertheless a profitable enterprise.
Countries that do not currently grant patents on life-sustaining drugs are, for the most part, countries with large populations.
In some countries specific processes for the manufacture of pharmaceutical drugs can be patented even in cases in which the drugs themselves cannot be patented.
Pharmaceutical companies can afford the research that goes into the development of new drugs only if patents allow them to earn high profits.
Countries that grant patents on life-sustaining drugs almost always ban their importation from countries that do not grant such patents.
P: 不受专利保护的药物在大众承受的起的价格，受专利保护的药物更加贵-> C :只有对维持生命的药物的专利保护废除了，这种药物在未来才有可能变得可得。
choice d, 只有专利允许制药公司获得高收益，公司才担负得起新药的研发工作。 correct
登录 或 注册 后可以参加讨论